Table 1.
Variable | All Participants Tested at Baseline | Completers 1-Year Post-Intervention | ||||
---|---|---|---|---|---|---|
Total (n = 44) |
ME (n = 23) |
UC (n = 21) |
Total (n = 44) |
ME (n = 23) |
UC (n = 21) |
|
Anthropometric | ||||||
Age (years) | 51.2 (7.9) | 50.4 (7.4) | 52.0 (8.5) | 50.7 (7.0) | 48.8 (5.7) | 52.8 (7.8) |
Weight (kg) | 62.9 (7.39) | 61.6 (6.32) | 64.3 (8.21) | 62.9 (7.87) | 61.3 (6.53) | 64.7 (6.95) |
Height (m) | 1.6 (0.05) | 1.6 (0.06) | 1.6 (0.06) | 1.6 (0.04) | 1.6 (0.05) | 1.6 (0.04) |
BMI | 24.57 (2.60) | 24.17 (2.07) | 24.98 (3.02) | 24.55 (2.48) | 23.89 (2.01) | 25.27 (2.77) |
Marital Status | ||||||
Married | 37/44 | 19 (82.6%) | 18 (85.7%) | 39/44 | 20 (87.0%) | 19 (90.5%) |
Single | 7/44 | 4 (17.4%) | 3 (14.3 %) | 5/44 | 3 (13.0%) | 2 (9.5%) |
Blood Pressure | ||||||
SBP at rest (mmHg) | 121.3 (20.6) | 117.7 (15.8) | 125.0 (24.3) | 121.6 (17.2) | 118.3 (13.9) | 125.3 (19.9) |
DBP at rest (mmHg) | 75.4 (10.6) | 77.0 (11.0) | 73.9 (10.2) | 76.1 (10.0) | 77.0 (11.2) | 75.2 (8.6) |
Mean Blood Pressure | 90.7 (12.6) | 90.5 (11.6) | 90.9 (13.7) | 91.3 (10.8) | 90.7 (11.0) | 91.9 (10.9) |
Stage of illness | ||||||
I | 18/60 | 8 (26.7%) | 10 (33.3%) | 16/44 | 6 (26.1%) | 10 (47.6%) |
Ⅱ | 33/60 | 19 (63.3%) | 14 (46.7%) | 23/44 | 15 (65.2%) | 8 (38.1%) |
Ⅲ | 9/60 | 3 (10.0%) | 6 (20.0%) | 5/44 | 2 (8.7%) | 3 (14.3%) |
PT | ||||||
Observation | 7/44 | 3 (13.0%) | 4 (19.0%) | 5/44 | 2 (8.7%) | 3 (14.3%) |
Chemotherapy | 15/44 | 7 (30.4%) | 8 (38.1%) | 18/44 | 9 (39.1%) | 9 (42.9%) |
Radiation therapy | 1/44 | 1 (4.3%) | 0(0%) | 0/44 | 0 (0%) | 0 (0%) |
Radio-chemotherapy | 21/44 | 12 (52.2%) | 9 (42.9%) | 20/44 | 12 (52.2%) | 8 (38.1%) |
SD, standard deviation; ME, multicomponent exercise group; UC, usual care group; BMI, Body Mass Index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PT, Phase of Treatment; KG, Kilogram. Values are n, mean (SD), or as otherwise indicated. Statistical evaluations were made by Analysis of Variance.